Skip to Main Navigation
Skip to Page Content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Share This:
https://ntp.niehs.nih.gov/go/17417

TDMS Study 99034-01 Pathology Tables

NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03
Route: GAVAGE                                                                                                     Time: 14:49:58

                                                         FINAL #1 MICE




       Facility:  Battelle Columbus Laboratory

       Chemical CAS #:  71-43-2

       Lock Date:  10/15/01

       Cage Range:  All

       Reasons For Removal:    All

       Removal Date Range:     All

       Treatment Groups:       Include All


































a  Number of animals examined microscopically at site and number of animals with lesion

                                                              Page   1


NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           15                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Intestine Small, Duodenum                          (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                                                            2 (13%)                               
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                                                        1 (7%)       1 (7%)                   
      Inflammation, Chronic                           10 (67%)      6 (40%)      6 (40%)      4 (27%)     11 (73%)                  
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Erosion                                                                                 1 (7%)                                
      Hyperplasia                                      1 (7%)                                                                       
      Inflammation, Chronic                                                      3 (20%)                                            
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                                                                       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Myocardium, Inflammation, Chronic                                                                    1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   Pituitary Gland                                    (15)         (15)         (15)         (15)         (15)                      
      Infiltration Cellular, Lymphoid                  1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    2                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
GENITAL SYSTEM - CONT                                                                                                               
   Clitoral Gland                                     (1)                                                                           
      Pigmentation                                     1 (100%)                                                                     
   Ovary                                              (14)         (15)         (15)         (15)         (15)                      
      Angiectasis                                                                                          1 (7%)                   
      Cyst                                             1 (7%)                                 2 (13%)      2 (13%)                  
   Uterus                                             (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                                                                         1 (7%)                   
      Inflammation, Suppurative                                                  1 (7%)       1 (7%)       1 (7%)                   
      Endometrium, Hyperplasia, Cystic                12 (80%)     15 (100%)    15 (100%)    15 (100%)    14 (93%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Lymph Node                                         (13)         (11)         (11)         (12)         (13)                      
      Lumbar, Hyperplasia, Lymphoid                                                                        1 (8%)                   
      Lumbar, Pigmentation                                                                                 1 (8%)                   
      Mediastinal, Atrophy                                                       2 (18%)      4 (33%)      2 (15%)                  
   Lymph Node, Mandibular                             (14)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       1 (7%)       2 (13%)      4 (27%)                               
      Hyperplasia, Lymphoid                            1 (7%)       4 (27%)      2 (13%)      5 (33%)      3 (20%)                  
      Infiltration Cellular, Polymorphonuclear         1 (7%)                                              2 (13%)                  
   Lymph Node, Mesenteric                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                       2 (13%)      3 (20%)      8 (53%)      6 (40%)                  
      Hyperplasia, Lymphoid                                                                                1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                 5 (33%)      5 (33%)      2 (13%)      3 (20%)      7 (47%)                  
      Infiltration Cellular, Lymphocyte                1 (7%)                                                                       
      Lymphoid Follicle, Atrophy                                    1 (7%)       1 (7%)                    1 (7%)                   
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia, Atypical                                         1 (7%)       1 (7%)       1 (7%)       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Mammary Gland                                      (15)         (15)         (15)         (15)         (15)                      
      Hyperplasia                                                                                          2 (13%)                  
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Granulomatous                      1 (7%)                    1 (7%)                                             
      Inflammation, Suppurative                                                               1 (7%)       1 (7%)                   
      Pigmentation                                                  1 (7%)       8 (53%)     15 (100%)    15 (100%)                 
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    3                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) FEMALE         0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Fibrosis                                                                   1 (7%)       1 (7%)       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                     2 (13%)      2 (13%)                                2 (13%)                  
      Alveolar Epithelium, Hyperplasia, Focal          1 (7%)                                              3 (20%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Casts Protein                                    5 (33%)      4 (27%)      5 (33%)      8 (53%)      7 (47%)                  
      Infiltration Cellular, Lymphoid                  1 (7%)                                                                       
      Infiltration Cellular, Lymphocyte                1 (7%)                                                                       
      Nephropathy                                      3 (20%)                   1 (7%)       2 (13%)      1 (7%)                   
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    4                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
DISPOSITION SUMMARY                                                                                                                 
                                                                                                                                    
  Animals Initially In Study                          15           15           15           15           15                        
  Early Deaths                                                                                                                      
    Moribund Sacrifice                                                                                     1                        
  Survivors                                                                                                                         
    Terminal Sacrifice                                15           15           15           15           14                        
                                                                                                                                    
  Animals Examined Microscopically                    15           15           15           15           15                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ALIMENTARY SYSTEM                                                                                                                  
                                                                                                                                    
   Liver                                              (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic                            3 (20%)      6 (40%)      1 (7%)       3 (20%)      1 (7%)                   
   Salivary Glands                                                                           (1)          (1)                       
      Submandibular Gland, Atrophy                                                                         1 (100%)                 
      Submandibular Gland, Inflammation, Chronic                                              1 (100%)                              
   Stomach, Forestomach                               (15)         (15)         (15)         (15)         (15)                      
      Erosion                                                                                              1 (7%)                   
      Hyperplasia                                      1 (7%)                                              3 (20%)                  
      Inflammation, Acute                                                                     1 (7%)                                
   Stomach, Glandular                                 (15)         (15)         (15)         (15)         (15)                      
      Mineralization                                                             1 (7%)                                             
      Glands, Cyst                                                               1 (7%)       1 (7%)                                
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 CARDIOVASCULAR SYSTEM                                                                                                              
                                                                                                                                    
   Heart                                              (15)         (15)         (15)         (15)         (15)                      
      Myocardium, Inflammation, Chronic                             1 (7%)       1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 ENDOCRINE SYSTEM                                                                                                                   
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENERAL BODY SYSTEM                                                                                                                
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                             Page    5                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 GENITAL SYSTEM                                                                                                                     
                                                                                                                                    
   Epididymis                                         (15)         (15)         (15)         (15)         (15)                      
      Granuloma Sperm                                                                                      1 (7%)                   
      Unilateral, Hypospermia                          1 (7%)                                                                       
   Testes                                             (15)         (15)         (15)         (15)         (15)                      
      Germinal Epithelium, Atrophy                                                            1 (7%)                                
      Germinal Epithelium, Syncytial Alteration                                               1 (7%)       1 (7%)                   
      Rete Testes, Inflammation, Granulomatous         1 (7%)                                                                       
      Unilateral, Germinal Epithelium, Atrophy         1 (7%)                                                                       
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 HEMATOPOIETIC SYSTEM                                                                                                               
                                                                                                                                    
   Bone Marrow                                        (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                                                10 (67%)     12 (80%)                  
      Pigmentation, Hemosiderin                        1 (7%)      13 (87%)     13 (87%)     15 (100%)    14 (93%)                  
   Lymph Node                                         (11)         (11)         (12)         (9)          (7)                       
      Mediastinal, Atrophy                                                       2 (17%)      6 (67%)      6 (86%)                  
   Lymph Node, Mandibular                             (15)         (15)         (15)         (14)         (14)                      
      Atrophy                                                                                 6 (43%)     11 (79%)                  
      Hyperplasia, Lymphoid                            2 (13%)      1 (7%)       1 (7%)                                             
      Infiltration Cellular, Polymorphonuclear                                                1 (7%)       1 (7%)                   
   Lymph Node, Mesenteric                             (15)         (15)         (14)         (15)         (15)                      
      Atrophy                                          1 (7%)       2 (13%)      2 (14%)     13 (87%)     13 (87%)                  
      Infiltration Cellular, Polymorphonuclear                                                             1 (7%)                   
   Spleen                                             (15)         (15)         (15)         (15)         (15)                      
      Hematopoietic Cell Proliferation                              1 (7%)                    2 (13%)      8 (53%)                  
      Lymphoid Follicle, Atrophy                                                             15 (100%)    14 (93%)                  
   Thymus                                             (15)         (15)         (15)         (15)         (15)                      
      Atrophy                                                                                 7 (47%)     13 (87%)                  
      Mineralization                                                                                       1 (7%)                   
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 INTEGUMENTARY SYSTEM                                                                                                               
                                                                                                                                    
   Skin                                               (15)         (15)         (15)         (15)         (15)                      
      Pigmentation                                                 15 (100%)    15 (100%)    15 (100%)    14 (93%)                  
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 MUSCULOSKELETAL SYSTEM                                                                                                             
                                                                                                                                    
   Bone                                               (15)         (15)         (15)         (15)         (15)                      
      Pigmentation, Hemosiderin                                                  1 (7%)                                             
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                             Page    6                                                              
                                                                                                                                   
NTP Experiment-Test: 99034-01         INCIDENCE RATES OF NONNEOPLASTIC LESIONS BY ANATOMIC SITE (a)               Report: PEIRPT03  
Study Type: SUBCHRON 26-WEEK                     TRANSGENIC MODEL EVALUATION II (BENZENE)                         Date: 11/05/03    
Route: GAVAGE                                                                                                     Time: 14:49:58    
____________________________________________________________________________________________________________________________________
                                                                                                                                    
         P16(INK4A)/(+/-) (C57BL/6) MALE           0 MG/KG      25 MG/KG     50 MG/KG     100          200                          
                                                                                          MG/KG        MG/KG                        
____________________________________________________________________________________________________________________________________
                                                                                                                                    
                                                                                                                                    
 NERVOUS SYSTEM                                                                                                                     
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 RESPIRATORY SYSTEM                                                                                                                 
                                                                                                                                    
   Lung                                               (15)         (15)         (15)         (15)         (15)                      
      Inflammation, Chronic Active                     2 (13%)                   1 (7%)       3 (20%)      5 (33%)                  
      Alveolar Epithelium, Hyperplasia, Focal                                    1 (7%)                                             
      Bronchiole, Hyperplasia, Focal                                             1 (7%)                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 SPECIAL SENSES SYSTEM                                                                                                              
                                                                                                                                    
   None                                                                                                                             
____________________________________________________________________________________________________________________________________
                                                                                                                                    
 URINARY SYSTEM                                                                                                                     
                                                                                                                                    
   Kidney                                             (15)         (15)         (15)         (15)         (15)                      
      Casts Protein                                    1 (7%)                    2 (13%)      1 (7%)       2 (13%)                  
      Nephropathy                                      1 (7%)       1 (7%)                    2 (13%)      4 (27%)                  
                                                                                                                                    
                                                                                                                                    
a  Number of animals examined microscopically at site and number of animals with lesion                                             
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                                                                                                    
                                                             Page    7                                                              
                                                                                                                                   
                             ------------------------------------------------------------                                           
                             ----------              END OF REPORT             ----------                                           
                             ------------------------------------------------------------